I think what's hurting Revance somewhat is that they don't expect to file, nor will they be on the market for a long time. I don't know why they are delaying the filing until next year with approval not expected before 2020?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.